Delivery Order SPE2DB22D3401-SPE2DB24FT2DR
- Not listed
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $1,734.42 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron ODT 8 mg tablets. The contract has a completion date of January 26, 2024 and was awarded on January 25, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ondansetron ODT 4 mg tablets. The contract has a potential value of $1,721.02 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp, a for-profit organization, provides pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This delivery order...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron ODT 4 mg tablets. The order, valued at $1,492.30, has a completion date of February 1, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and is not subject to any set-aside designations. The company holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of Ondansetron ODT 4 mg tablets. The order, valued at $3,672.70, has a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $22,012.59 to provide Ondansetron ODT 4 mg tablets. The contract has a performance period through January 31, 2024 and was not set aside for any specific business category. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC) valued up...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $9,264.51 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,605,115 units of the medication Ondansetron ODT 4 mg Tablet 30s. The delivery order has a completion date of February 9, 2024. Amerisourcebergen Drug Corp is a prime contractor that holds an indefinite delivery contract with DLA valued at up to $999,999,999.00, which serves as the primary vehicle for the...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $10,834.11 firm fixed price delivery order contract to supply 4,564,205 units of 4 mg Ondansetron HCL tablets. The contract has an ultimate completion date of April 9, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and the parent company Cencora, Inc. conducts business as Amerisourcebergen. This delivery order is part of a...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of ondansetron ODT 4 mg tablets. The contract has a completion date of January 30, 2024 and a potential value of $5,983.56. Amerisourcebergen Drug Corp is the prime contractor and this delivery order is part of a larger indefinite delivery contract (IDC) with DLA valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $7,200.46 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron ODT 4 MG tablets. This delivery order contract has a completion date of January 26, 2024 and was awarded on January 25, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, to deliver...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,405.39 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4564176739 - Ondansetron ODT 4 MG Tablet 30s, a pharmaceutical product. The contract has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB24FT2DRDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,751.81 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563891985 Ondansetron ODT 4 mg tablets. This delivery order contract has a completion date of March 8, 2024 and was awarded on March 7, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with DLA with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 3/7/24 |